Clinical Trials on Intermediate Risk
Total 2333 results
-
InSightecUnknownLocalized Intermediate Risk Prostate LesionsUnited States
-
Forma Therapeutics, Inc.RecruitingVery Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-RUnited States, France, Canada, Germany
-
Azienda Socio Sanitaria Territoriale degli Spedali...TakedaUnknownIntermediate Risk Prostate Cancer | High Risk Prostate CancerItaly
-
The First Affiliated Hospital of Soochow UniversityRecruitingHigh Risk Acute Myeloid Leukemia | Intermediate Risk Acute Myeloid LeukemiaChina
-
Peking Union Medical College HospitalUnknownLow/Intermediate Risk-1 MDSChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMyelodysplastic Syndrome | High Risk Myelodysplastic Syndrome | IPSS Risk Category Intermediate-1United States
-
RPCR, Inc.UnknownProstate Cancer Early Risk Treated by Radiosurgery | Prostate Cancer Intermediate Risk Treated by RadiosurgeryUnited States
-
Dana-Farber Cancer InstituteMedivation, Inc.Completed
-
Henry Ford Health SystemAmerican Cancer Society, Inc.WithdrawnLow or Intermediate Risk Prostate CancerUnited States
-
InSightecCompletedLocalized Low-Intermediate Risk Prostate CancerUnited Kingdom, Israel, Canada, Italy, Singapore
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Adelphi University; Queen's Hospital CenterCompletedSurvey | Risk Perception | Cancer Related-Risks | Focus GroupUnited States
-
Centre Francois BaclesseFrench cancer Institute INCaRecruitingThyroid Cancer | Intermediate RiskFrance
-
Centre Francois BaclesseTerminatedProstate Cancer With Intermediate RiskFrance
-
University Health Network, TorontoClinical Laserthermia Systems ABUnknownProstate Cancer | Low and Intermediate Risk Prostate CancerCanada
-
NHS LothianNot yet recruitingLow Risk Prostate Cancer | Intermediate Risk Prostate Cancer | Localized Prostate Cancer
-
EBG MedAustron GmbHRecruitingLow Risk Prostate Cancer | Intermediate Risk Prostate CancerAustria
-
University of OxfordVaccitech (UK) LimitedUnknownCastration-resistant Prostate Cancer | Intermediate Risk Prostate CancerUnited Kingdom
-
Genesis Research LLCRecruitingProstate Cancer | Low-risk or Favorable Intermediate Risk Prostate Cancer Who Are on an Active Surveillance RegimenUnited States
-
PhotocureKarl StorzCompletedIntermediate or High-risk Bladder Cancer
-
French Innovative Leukemia OrganisationAbbVie; Janssen-Cilag Ltd.Active, not recruitingIntermediate Risk Chronic Lymphocytic Leukemia | Fit Patients | Risk-Adapted and MRD-Driven StrategyFrance
-
Meshalkin Research Institute of Pathology of CirculationUnknownPulmonary Embolism | Intermediate-high Risk | Combination of Oral Anticoagulation Therapy and SildenafilRussian Federation
-
EyePoint Pharmaceuticals, Inc.CompletedPanuveitis | Posterior Uveitis | Intermediate UveitisIndia
-
Johns Hopkins UniversityMacuSight, Inc.CompletedPanuveitis | Uveitis | Posterior Uveitis | Intermediate UveitisUnited States
-
Weizmann Institute of ScienceHadassah Medical OrganizationRecruitingDietary Fibers | Intermediate FastingIsrael
-
Priovant Therapeutics, Inc.Active, not recruitingNon-infectious Intermediate Uveitis | Non-infectious Posterior Uveitis | Non-infectious Pan UveitisUnited States
-
Celgene CorporationCompletedLow- or Intermediate-1-risk Myelodysplastic Syndrome (MDS)United States
-
Duke UniversityCompletedPosterior Uveitis | Intermediate UveitisUnited States
-
AllerganCompletedPosterior Uveitis | Intermediate UveitisFrance, United Kingdom, United States, Spain, Poland, India, South Africa, Korea, Republic of, Canada, Czech Republic, Australia, Germany, Israel, Switzerland, Portugal, Austria, Brazil, Greece
-
Salzburger LandesklinikenCompletedIntermediate Cervical Plexus Block for Carotid EndarterectomyAustria
-
University of NebraskaUnknownPosterior Uveitis | Intermediate Uveitis | Pan-uveitisUnited States
-
Novartis PharmaceuticalsCompletedNon-infectious Intermediate Uveitis | Non-infectious Posterior Uveitis | Non-infectious PanuveitisUnited States, United Kingdom
-
Yonsei UniversityRecruitingAtrial Fibrillation Patients With Intermediate Stroke RiskKorea, Republic of
-
Stanford UniversitySanten Inc.WithdrawnPanuveitis | Uveitis | Posterior Uveitis | Intermediate UveitisUnited States
-
CHU de Quebec-Universite LavalCompletedIntermediate Uveitis | Anterior UveitisCanada
-
University Health Network, TorontoPrincess Margaret Hospital, CanadaActive, not recruitingLow or Intermediate Risk Prostate CancerCanada
-
Turku University HospitalRecruitingProstate Cancer | Localized Prostate Carcinoma | Intermediate Risk Prostate Cancer | Castration-Naive Prostate CancerFinland
-
University Hospital, GrenobleRecruitingRadiation Therapy, Breast Cancer, Sequential Partial Breast Irradiation | Intermediate and High-risk Luminal and Triple Negative Breast CancerFrance
-
Rennes University HospitalNot yet recruitingHysterectomies for Low- or Intermediate-risk Endometrial CarcinomaFrance
-
AbbVieCompletedNon-infectious Intermediate, Posterior and PanuveitisKorea, Republic of
-
Washington State UniversityUnknownSubstance Abuse | Risk Reduction | RIsky Sexual BehaviorUnited States
-
St. Franziskus HospitalCompleted
-
University of Sao PauloCompletedTo Study the Influence of an Multifocal Intraocular Lens With Different Addition on Intermediate Visual AcuityBrazil
-
University of Southern DenmarkRegion of Southern Denmark; Odense Patient Data Explorative Network; ENIGMA Solutions... and other collaboratorsActive, not recruitingCardiovascular Risk Factor | Risk CommunicationDenmark
-
EyePoint Pharmaceuticals, Inc.TerminatedUveitis | Uveitis, Posterior | Uveitis, IntermediateUnited States
-
Ohio State University Comprehensive Cancer CenterCompletedIndolent or Intermediate Grade B-cell MalignancyUnited States
-
Forsight Vision4TerminatedUveitis, Posterior | Uveitis, IntermediateUnited States
-
University Hospital, BordeauxRecruitingMetastatic Renal Cell Carcinoma | Good or Only One Adverse Prognostic Factor Intermediate Risk Per IMDC ScoreFrance
-
Bournemouth UniversityDorset HealthCare University NHS Foundation TrustWithdrawnRisk Behavior | Violence | Risk Behavior, Health
-
STZ eyetrialNovartis Pharmaceuticals; University Hospital TuebingenCompletedUveitis, IntermediateGermany
-
Tampa Bay Uveitis Center, LLCMallinckrodtCompletedUveitis | Posterior Uveitis | Intermediate Uveitis | Anterior Uveitis | Scleritis | Clinically Significant Macular EdemaUnited States